Evidence map›Paper›PMID 37863670›Full record

ArticleVaccine2023

Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].

Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, Hyeong-Jun Park, Sohyun Park, You-Jin Kim, Hae Li Ko and 17 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Hye Won KwakDepartment of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; BK Plus Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; SML Biopharm, Gyeonggi-do, Bucheon, Republic of Korea.
Hyo-Jung ParkDepartment of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; BK Plus Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea.
Seo-Yeon JungDepartment of R&D, SK Bioscience, Pangyoro, Bundang-gu, Republic of Korea.
Eun Young OhCollege of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
Sang-In ParkDivision of Research Program, Scripps Korea Antibody Institute, Chuncheon, Kangwon-do, Republic of Korea.
Yeonhwa KimCollege of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
Hyeong-Jun ParkDepartment of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; BK Plus Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; SML Biopharm, Gyeonggi-do, Bucheon, Republic of Korea.
Sohyun ParkCollege of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
You-Jin KimDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Hae Li KoDivision of Research Program, Scripps Korea Antibody Institute, Chuncheon, Kangwon-do, Republic of Korea.
Jung-Ah LeeDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Hyeran WonDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Yun-Ho HwangDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Seo Yeon KimDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Se Eun KimDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Seong Eun BaeScience Unit, International Vaccine Institute, Seoul 08826, Republic of Korea.
Minhyuk YoonScience Unit, International Vaccine Institute, Seoul 08826, Republic of Korea.
Jae-Ouk KimScience Unit, International Vaccine Institute, Seoul 08826, Republic of Korea.
Manki SongScience Unit, International Vaccine Institute, Seoul 08826, Republic of Korea.
Su Jeen LeeDepartment of R&D, SK Bioscience, Pangyoro, Bundang-gu, Republic of Korea.
Ki-Weon SeoDepartment of R&D, SK Bioscience, Pangyoro, Bundang-gu, Republic of Korea.
Kunse LeeDepartment of R&D, SK Bioscience, Pangyoro, Bundang-gu, Republic of Korea.
Dokeun KimDivision of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Republic of Korea.
Hun KimDepartment of R&D, SK Bioscience, Pangyoro, Bundang-gu, Republic of Korea.
Sang-Myeong LeeCollege of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea. Electronic address: smlee@chungbuk.ac.kr.
So-Hee HongDepartment of Microbiology, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea. Electronic address: shhong13@ewha.ac.kr.
Jae-Hwan NamDepartment of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; BK Plus Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea. Electronic address: jhnam@catholic.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37863670
PMCPMC11021202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.